Results 81 to 90 of about 28,144 (206)

Non-valvular atrial fibrillation: impact of apixaban on patient outcomes

, 2017
Adam Ioannou,1 Irene Tsappa,2 Sofia Metaxa,3 Constantinos G Missouris2,3 1Cardiology Department, Royal Free NHS Foundation Trust, London, UK; 2Cardiology Department, Medical School, University of Cyprus, Nicosia, Cyprus; 3Cardiology Department, Frimley ...
Metaxa S, Missouris CG, Ioannou A, Tsappa I   +3 more
core  

Risk of Severe Hypoglycemia Associated With Concomitant Use of Sulfonylureas and Amiodarone

Diabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 9336-9345, October 2026.
ABSTRACT Aims To evaluate whether initiation of amiodarone while receiving sulfonylurea is associated with an increased risk of severe hypoglycemia compared with the initiation of other antiarrhythmic agents (flecainide, sotalol, or propafenone) while receiving sulfonylurea. Materials and Methods We conducted a population‐based cohort study using South
Sungho Bea, Hyesung Lee, Young Min Cho, You‐Jung Choi, Ju‐Young Shin, Katsiaryna Bykov   +5 more
wiley   +1 more source

Apixaban in patients with atrial fibrillation

, 2011
BACKGROUND: Vitamin K antagonists have been shown to prevent stroke in patients with atrial fibrillation. However, many patients are not suitable candidates for or are unwilling to receive vitamin K antagonist therapy, and these patients have a high ...
Eikelboom J, Yusuf S, Commerford P, Avezum A, Lip GY, Diener HC, Munawar M, Dans AL, Afzal R, Talajic M, Tan RS, Hart R, Connolly SJ, Lawrence J, Pais P, Joyner C, Flaker G, Lanas Zanetti F, Gonzalez Hermosillo A, Budaj A, Diaz R, Lewis BS, Hohnloser SH, Zhu J, Jansky P, Van Mieghem W, Parkhomenko A, GLORIOSO, Nicola Filippo, O'Donnell M, Kim JH, Golitsyn S, Sim KH, Lewis G   +32 more
core   +1 more source

Clinically Relevant Bleeding in Individuals With Cancer: Insights From a Nationwide Cohort Study

American Journal of Hematology, Volume 101, Issue 9, Page 2123-2136, September 2026.
ABSTRACT Cancer care is often complicated by coagulopathy leading to thrombosis and bleeding. While venous thromboembolism (VTE) has been extensively studied, bleeding remains an underestimated threat. To address this knowledge gap, we leveraged the Epic Cosmos database to determine the impact of cancer‐associated clinically relevant bleeding (CRB) in ...
Ming Y. Lim, Radhika Gangaraju, Omid Jafari, Zihan Yang, Joyce W. T. Tiong, Elizabeth C. L. Chiang, Shengling Ma, Jun Y. Jiang, Justine Ryu, Barbara D. Lam, Mrinal Ranjan, Ang Li   +11 more
wiley   +1 more source

Compounded Apixaban Suspensions for Enteral Feeding Tubes

, 2016
Objective: There is limited information on compounded apixaban formulations for administration via enteral feeding tubes. This study was designed to identify a suitable apixaban suspension formulation that is easy to prepare in a pharmacy setting, is ...
Maria L. Caraballo, Caraballo, Maria, Zhao, Fang, Donmez, Seda, Nathan, Kobi T, Seda Donmez, Kobi Nathan, Fang Zhao   +7 more
core   +1 more source

Apixaban: Eliquis® [díptic]

, 2018
Anticoagulants orals d’acció directa; Apixaban; MedicamentsAnticoagulantes orales de acción directa; Apixaban; MedicamentosDirect-acting oral anticoagulants; Apixaban; MedicinesPreguntes i respostes sobre l’anticoagulant oral d’acció directa, Apixaban ...

core  

The Impact of a Visualized Steerable Sheath on Radiofrequency Catheter Ablation for First‐Time Atrial Fibrillation Ablation: A Prospective, Randomized, Single‐Blind Study

Catheterization and Cardiovascular Interventions, Volume 108, Issue 3, Page 924-934, September 1, 2026.
ABSTRACT Background A 3D electroanatomical mapping (3D‐EAM) visualized steerable sheath was designed to improve catheter placement and reduce radiation exposure during ablation, an established treatment for atrial fibrillation (AF). However, prospective randomized data comparing the procedural and clinical outcomes of visualized and non‐visualized ...
Chun‐Kai Chen, Chih‐Chieh Yu, Min‐Tsun Liao, Hui‐Chun Huang, Yen‐Bin Liu   +4 more
wiley   +1 more source

Acute severe renal failure in a patient receiving apixaban: a case report

Italian Journal of Medicine
Because there is little clinical experience with apixaban in patients with severe renal impairment and non-valvular atrial fibrillation, the European Medicines Agency does not advise using it to prevent strokes in these patients.
Attilia Maria Pizzini, Chiara Fantoni, Stefania Zaccaroni, Mauro Silingardi   +3 more
doaj   +1 more source

Reducing the risk of venous thromboembolism using apixaban – patient perspectives and considerations. Should more attention be given to females?

, 2016
Fabio Fabbian, Alfredo De Giorgi, Ruana Tiseo, Beatrice Zucchi, Roberto Manfredini School of Medicine, University of Ferrara, Ferrara, Italy Background: New oral anticoagulant agents, such as apixaban, rivaroxaban, dabigatran, or endoxaban, have ...
Manfredini R, Tiseo R, Zucchi B, Fabbian F, De Giorgi A   +4 more
core  

Safety and Efficacy of Apixaban in the Treatment of Atrial Fibrillation

, 2012
Atrial fibrillation is a common arrhythmia that increases the risk of stroke and systemic embolism. Warfarin is a highly effective treatment in reducing this risk, but a narrow therapeutic range, drug and food interactions, required monitoring, and ...
Ralph Stewart, Andrew Martin
core   +1 more source